BioSpace News Archive

Business

Celcuity Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Celcuity Inc., a clinical-stage biotechnology company focused on development of targeted therapies for a number of different cancers, announced financial results for the second quarter ended June 30, 2022 and other recent business developments.

August 11, 2022
·
15 min read
Business

AN2 Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, reported financial results for the quarter ended June 30, 2022.

August 11, 2022
·
8 min read
Business

Vor Bio Reports Second Quarter 2022 Financial Results and Provides Company Update

Vor Bio, a clinical-stage cell and genome engineering company, reported financial results for the three-month period ended June 30, 2022, and provided a business update.

August 11, 2022
·
9 min read
Business

SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2022 Financial Results

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, provided a business update and reported its financial results for the quarter ended June 30, 2022.

August 11, 2022
·
13 min read
Business

Savara Reports Second Quarter 2022 Financial Results and Provides Business Update

Pivotal Phase 3 IMPALA-2 Trial of Novel Inhaled Biologic, Molgramostim Nebulizer Solution, in Autoimmune Pulmonary Alveolar Proteinosis Remains On-Track IMPALA-2 Top Line Data Expected at the End of 2Q 2024 Company Ends Quarter with ~$142M – Believes it is Sufficiently Capitalized Through 2025

August 11, 2022
·
6 min read
Business

AskBio Bolsters its Global Leadership Team with Two New Executives

Asklepios BioPharmaceutical , Inc. is adding two industry veterans to advance clinical operations and lead corporate communications.

August 11, 2022
·
5 min read
BioMidwest

Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities

Brainlab announced today the first group of breast cancer patients treated in United States with the ExacTrac Dynamic® Deep Inspiration Breath Hold (DIBH) module.

August 11, 2022
·
4 min read
Biomarker Testing Services Market Size, Growth, Trends | Report 2022-2030

The global biomarker testing services market is expected to register significant growth in the forecast period.

August 11, 2022
·
2 min read
Cancer Monoclonal Antibodies Market Size, Trends, Growth | Report 2022-2030

The global cancer monoclonal antibodies market was surpassed at USD 62.2 billion in 2021 and is expected to hit around USD 159.96 billion by 2030, growing at a CAGR of 11.07% from 2022 to 2030

August 11, 2022
·
7 min read
Cell and Gene Therapy Market Size, Growth, Trends, Forecast Report 2022-2030

According to Vision Research Reports, the global cell and gene therapy market size is expected to hit around USD 42.56 billion by 2030, growing at a CAGR of 39.42 % during the forecast period 2022 to 2030.

August 11, 2022
·
11 min read